Drug development blossoms for rare, fatal bone disease.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
medline:
30
5
2024
pubmed:
30
5
2024
entrez:
30
5
2024
Statut:
ppublish
Résumé
Five drugs are now approved or in trials for genetic condition that triggers misplaced bone growth.
Identifiants
pubmed: 38815021
doi: 10.1126/science.adq7356
doi:
Substances chimiques
odanacatib
N673F6W2VH
romosozumab
3VHF2ZD92J
Antibodies, Monoclonal
0
Biphenyl Compounds
0
Types de publication
News
Langues
eng
Sous-ensembles de citation
IM